National Heart, Lung, and Blood Institute; Amended Notice of Meeting
---
identifier: "/us/fr/2019-07966"
source: "fr"
legal_status: "authoritative_unofficial"
title: "National Heart, Lung, and Blood Institute; Amended Notice of Meeting"
title_number: 0
title_name: "Federal Register"
section_number: "2019-07966"
section_name: "National Heart, Lung, and Blood Institute; Amended Notice of Meeting"
positive_law: false
currency: "2019-04-22"
last_updated: "2019-04-22"
format_version: "1.1.0"
generator: "[email protected]"
agency: "Health and Human Services Department"
document_number: "2019-07966"
document_type: "notice"
publication_date: "2019-04-22"
agencies:
- "Health and Human Services Department"
- "National Institutes of Health"
fr_citation: "84 FR 16683"
fr_volume: 84
---
# National Heart, Lung, and Blood Institute; Amended Notice of Meeting
Notice is hereby given of a change in the duration of the meeting of the Clinical Trials Review Committee, June 20, 2019, 8:00 a.m. to June 21, 2019, 5:00 p.m., Hilton Garden Inn Bethesda, 7301 Waverly Street, Bethesda, MD 20814 which was published in the *Federal Register* on February 15, 2019, 84 FR 4490.
The Clinical Trials Review Committee will be reduced to a one-day meeting on June 20, 2019 in the same location. The meeting is closed to the public.
Dated: April 16, 2019.
Ronald J. Livingston, Jr.,
Program Analyst, Office of Federal Advisory Committee Policy.